Publicaciones en colaboración con investigadores/as de Hospital Infanta Sofia (8)

2024

  1. The CAPN3 p.Lys 254del variant is not always associated with dominant CAPN3-related muscular dystrophy

    Muscle and Nerve, Vol. 69, Núm. 4, pp. 472-476

2023

  1. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

2022

  1. Drug-refractory myasthenia gravis: Clinical characteristics, treatments, and outcome

    Annals of Clinical and Translational Neurology, Vol. 9, Núm. 2, pp. 122-131

2020

  1. Effectiveness and safety of perampanel monotherapy for focal and generalized tonic-clonic seizures: Experience from a national multicenter registry

    Epilepsia, Vol. 61, Núm. 6, pp. 1109-1119

2019

  1. MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy

    Epilepsy and Behavior, Vol. 97, pp. 51-59

  2. Muscle MRI in a large cohort of patients with oculopharyngeal muscular dystrophy

    Journal of Neurology, Neurosurgery and Psychiatry, Vol. 90, Núm. 5, pp. 576-585

2017

  1. EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure

    Acta Neurologica Scandinavica, Vol. 136, Núm. 3, pp. 254-264

2016

  1. Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes

    Neuromuscular Disorders, Vol. 26, Núm. 1, pp. 33-40